Earnings (Loss) Per Common Share

3 Months Ended

Mar. 31, 2020

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):



	For the Three Months Ended March 31,
	2020			2019
Net loss	$	(78,752	)	$	(48,649	)
Less:
Net loss attributable to non-controlling interests	—			(1,910		)
Net loss available for common shareholders - basic and diluted ⁽¹⁾	$	(78,752	)	$	(46,739	)

Weighted-average common shares outstanding - basic and diluted ⁽¹⁾	84,793			79,335

Loss per common share
Basic and diluted	$	(0.93	)	$	(0.59	)

⁽¹⁾ Each Class B common unit of Evolent Health LLC can be exchanged (together with a corresponding number of shares of our Class B common stock) for one share of our Class A common stock. As holders exchange their Class B common shares for Class A common shares, our interest in Evolent Health LLC will increase. Therefore, shares of our Class B common stock are not considered dilutive shares for the purposes of calculating our diluted earnings (loss) per common share as related adjustment to net income (loss) available for common shareholders would equally offset the additional shares, resulting in the same earnings (loss) per common share.

Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:



	For the Three Months Ended March 31,
	2020	2019
Exchangeable Class B common stock	—	3,190
RSUs	199	1,043
Stock options	972	1,966
Convertible senior notes	10,361	10,361
Total	11,532	16,560